These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38425144)

  • 1. Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics.
    Ding Y; Chen Y; Sun J; Shi Y; Li G; Luan X; Wang S; Li X; Jiang W; Wang L; Zhang G
    Ann Clin Transl Neurol; 2024 May; 11(5):1184-1196. PubMed ID: 38425144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica.
    Long Y; Qiu W; Lu Z; Bao J; Wu A; Wang Y; Wang H; Hu X
    Neuroimmunomodulation; 2012; 19(2):96-102. PubMed ID: 22248725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
    Bennett JL; Lam C; Kalluri SR; Saikali P; Bautista K; Dupree C; Glogowska M; Case D; Antel JP; Owens GP; Gilden D; Nessler S; Stadelmann C; Hemmer B
    Ann Neurol; 2009 Nov; 66(5):617-29. PubMed ID: 19938104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis.
    Lin N; Liu Q; Wang X; Ma J; Li Y
    Protein Pept Lett; 2017; 24(3):245-252. PubMed ID: 28071581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
    Jarius S; Franciotta D; Paul F; Ruprecht K; Bergamaschi R; Rommer PS; Reuss R; Probst C; Kristoferitsch W; Wandinger KP; Wildemann B
    J Neuroinflammation; 2010 Sep; 7():52. PubMed ID: 20825655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Ishii N; Itoyama Y
    Tohoku J Exp Med; 2006 Dec; 210(4):307-13. PubMed ID: 17146196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
    Jarius S; Wildemann B
    Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations.
    Kowarik MC; Dzieciatkowska M; Wemlinger S; Ritchie AM; Hemmer B; Owens GP; Bennett JL
    J Neuroinflammation; 2015 Jan; 12():19. PubMed ID: 25626447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biomarkers in neuromyelitis optica].
    Misu T; Takahashi T; Nakashima I; Fujihara K
    Brain Nerve; 2012 May; 64(5):525-35. PubMed ID: 22570066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica: a pilot study of clinical presentation and status of serological biomarker AQP4 among patients admitted to a tertiary centre in NCNS, Sudan.
    Ibrahim EAA; Gammer F; Gassoum A
    BMC Neurosci; 2020 Feb; 21(1):9. PubMed ID: 32111161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
    Kim YJ; Jung SW; Kim Y; Park YJ; Han K; Oh EJ
    J Clin Lab Anal; 2012 May; 26(3):184-9. PubMed ID: 22628234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
    Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
    Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.
    Saiz A; Zuliani L; Blanco Y; Tavolato B; Giometto B; Graus F;
    J Neurol; 2007 Sep; 254(9):1233-7. PubMed ID: 17401734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
    Mader S; Gredler V; Schanda K; Rostasy K; Dujmovic I; Pfaller K; Lutterotti A; Jarius S; Di Pauli F; Kuenz B; Ehling R; Hegen H; Deisenhammer F; Aboul-Enein F; Storch MK; Koson P; Drulovic J; Kristoferitsch W; Berger T; Reindl M
    J Neuroinflammation; 2011 Dec; 8():184. PubMed ID: 22204662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
    PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.